By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Australian diagnostics firm Universal Biosensors on Monday announced it has signed a non-exclusive license that provides it access to SpeeDx's proprietary MNAzyme technology.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.
Researchers report that what scents someone picks up can reflect their complement of immune genes.
The New York Times examines ethics and China's push to lead biomedical research.
At her blog, Sally Rockey dives into National Institutes of Health funding data.